Design
This was an IRB-approved, prospective phase II clinical trial of laparoscopic CRS/HIPEC (NCT02463877). Data may be shared in a de-identified form upon request, with an IRB-approved research plan. The primary endpoint of the study was 30-day postoperative morbidity, defined according to the validated system proposed by Clavien [